Concentration-dependent tubular secretion of acetazolamide and its inhibition by salicylic acid in the isolated perfused rat kidney

Drug Metabolism and Disposition

Volumn 24, Issue 4, 1996, Pages 456-461

  Taft, David R ^a,b   Chapron, Dennis J ^a   Fournier, Donna J ^a   Sweeney, Kevin R ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; SALICYLIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DISPOSITION; DRUG INHIBITION; GLOMERULUS FILTRATION; KIDNEY CLEARANCE; KIDNEY PERFUSION; KIDNEY TUBULE EXCRETION; METABOLIC CLEARANCE RATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; XENOBIOTIC METABOLISM;

ACETAZOLAMIDE; ALBUMINS; ANIMALS; DIURETICS; DRUG INTERACTIONS; KIDNEY; KIDNEY TUBULES; MALE; PERFUSION; PROTEIN BINDING; RATS; SALICYLIC ACID; SALICYLIC ACIDS;

EID: 0029965835     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. I. Bekersky and W. A. Colburn: Renal clearance of carprofen in the isolated perfused rat kidney Drug Metab. Dispos. 9, 25-29 (1981).
2. P. G. F. Cox, M. M. Moons, J. F. G. Slegers, F. G. M. Russel, and C. A. M. van Ginneken: Isolated perfused rat kidney as a tool in the investigation of renal handling and effects of nonsteroidal antinflammatory drugs. J. Pharmacol Methods 24, 89-103 (1990).
3. P. Statkevich, D. J. Fournier, and K. R. Sweeney: Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 265, 1118-1124 (1993).
4. A. A. Somogyi, C. M. Hovens, M. R. Muirhead, and F. Bochner: Renal tubular secretion of amiloride and its inhibition by cimetidine in humans and in an animal model. Drug Metab. Dispos. 17, 190-196 (1989).
5. P. J. Wistrand: The use of carbonic anhydrase inhibitors in ophthalmology and clinical medicine. Ann. NY Acad. Sci. 429, 609-619 (1984).
6. D. J. Chapron, K. R. Sweeney, P. U. Feig, and P. A. Kramer: Influence of advanced age on the disposition of acetazolamide. Br. J. Clin. Pharmacol. 19, 363-371 (1985).
7. K. R. Sweeney, D. J. Chapron, E. J. Antal, and P. A. Kramer: Differential effects of flurbiprofen and aspirin on acetazolamide disposition in humans. Br. J. Clin. Pharmacol. 27, 866-869 (1989).
8. R. H. Bowman: The perfused rat kidney. Methods Enzymol. 39, 3-11 (1975).
9. J. M. Nishiitsutsuji-Uwo, B. D. Ross, and H. A. Krebs: Metabolic activities of the isolated perfused rat kidney. Biochem. J. 103, 852-862 (1967).
10. I. Bekersky: The isolated perfused kidney as a pharmacological tool. Drug Metab. Rev. 14, 931-960 (1983).
11. F. H. Epstein, J. T. Brosnan, J. D. Tange, and B. D. Ross: Improved function with amino acids in the isolated perfused kidney. Am. J. Physiol. 243, F284-F292 (1982).
12. S. D. Hall and M. Rowland: A simple system for the investigation of protein binding effects on the renal handling of drugs in an isolated perfused rat kidney preparation. J. Pharmacol. Methods 12, 85-89 (1984).
13. D. R. Taft and K. R. Sweeney: Influence of protein binding on the elimination of acetazolamide by the isolated perfused rat kidney: evidence of albumin-mediated tubular secretion. J. Pharmacol. Exp. Ther. 265, 752-760 (1995).
14. K. R. Sweeney, D. J. Chapron, and P. A. Kramer: Effect of salicylate on serum protein binding and red blood cell uptake of acetazolamide in vitro. J. Pharm. Sci. 77, 751-756 (1988).
15. L. J. Lee, J. A. Cook, and D. E. Smith: Renal transport kinetics of furosemide in the isolated perfused rat kidney. J. Pharmacokinet. Biopharm. 14, 157-174 (1986).
16. P. G. F. Cox, M. M. Moons, F. G. M. Russel, and C. A. M. van Ginneken: Renal handling and effects of salicylic acid in the isolated perfused rat kidney. Pharmacol. Toxicol. 69, 322-328 (1991).
17. L. J. Lee, J. A. Cook, and D. E. Smith: Renal transport kinetics of chlorothiazide in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 247, 203-208 (1988).
18. I. H. Gomolin and D. J Chapron: Elucidating the relationship between acetazolamide plasma protein binding and renal clearance using an albumin infusion. J. Clin. Pharmacol. 32, 1028-1032 (1992).
19. T. Maack: Physiological evaluation of the isolated perfused rat kidney. Am. J. Physiol. 238, F71-F78 (1980).
20. F. G. M. Russel, A. C Wouterse, P. Hekman, G. J. Grutters, and C. A. M. van Ginneken: Quantitative urine collection in renal clearance studies in the dog. J. Pharmacol. Methods 17, 125-136 (1987).
21. 125I-albumin to rat hepatocytes. Gastroenterology 79, 1041 (abstr.) (1980).
22. R. Weisiger, J. Gollan, and R. Ockner: Receptor for albumin on the liver cell surface may mediate hepatic uptake of sulfobromophthalein and bilirubin. Science 211, 1048-1051 (1981).
23. R. K. Ockner, R. A. Weisiger, and J. L. Gollan: Hepatic uptake of albumin-bound substances: albumin receptor concept. Am. J. Physiol. 245, G13-G18 (1983).
24. L. Bass and S. M. Pond: The puzzle of rates of cellular uptake of protein bound ligands. In "Pharmacokinetics: Mathematical and Statistical Approaches" (A. Pecite and A. Rescigno, eds.), pp. 221-245. Plenum Press, New York, 1989.
25. R. A. Weisiger, S. Pond, and L. Bass: Hepatic uptake of protein-bound ligands. extended sinusoidal perfusion model. Am. J. Physiol. 261, G872-G884 (1991).
26. T. Horie, T. Mizuma, K. Kasai, and S. Awazu: Conformational change in plasma albumin due to interaction with isolated rat hepatocyte. Am. J. Physiol. 254, G465-G470 (1988).
27. T. H. Maren. Carbonic anhydrase: chemistry, physiology and inhibition. Physiol. Rev. 47, 595-781 (1967).